Skip to main content

What the FDA labels say about taking them together

Cangrelor and clopidogrel

Cangrelor's FDA label of October 21, 2025 names clopidogrel in its drug interactions section; the clopidogrel label PlainMeds reads does not name cangrelor. The cangrelor label: “DRUG INTERACTIONS Clopidogrel: Do not administer during KENGREAL infusion.”

Check it at the source: the cangrelor FDA label on DailyMed (effective October 21, 2025, Chiesi USA, Inc.); the clopidogrel FDA label on DailyMed (effective May 30, 2025, Sanofi-Aventis U.S. LLC).

What does the cangrelor label say about clopidogrel?

Cangrelor label, drug interactions

DRUG INTERACTIONS Clopidogrel: Do not administer during KENGREAL infusion.

Cangrelor label, warnings and precautions

In CHAMPION PHOENIX bleeding events of all severities were more common with KENGREAL than with clopidogrel [see Adverse Reactions ( 6.1 )].

Source: FDA drug label (KENGREAL), Chiesi USA, Inc., effective October 21, 2025 (SPL set 88b434fa-8891-4fd5-9d86-7ea64667c08f), via openFDA; the full label on DailyMed

What does the clopidogrel label say about cangrelor?

Clopidogrel's label (effective May 30, 2025) does not name cangrelor in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Plavix), Sanofi-Aventis U.S. LLC, effective May 30, 2025 (SPL set de8b0b67-eb25-4684-83b5-7ad785314227), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

1Cangrelor generic labelers
35Clopidogrel generic labelers
CangrelorClopidogrel
Labeled forHeart attack and coronary artery diseaseHeart attack and coronary artery disease, Angina
Boxed warningNoYes
Pharmacy cost (NADAC)n/a$0.0472 per tablet 75 mg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?